Biogen Idec Inc. (NASDAQ:BIIB) – Sobi’s partner Biogen Idec receives notification from FDA of PDUFA date extension for ALPROLIX(TM)

[at noodls] – More news 2013-12-02 Sobi’s partner receives notification of PDUFA extension for ALPROLIX Swedish Orphan Biovitrum AB’s (publ) (Sobi) partner Biogen Idec announced today that the U.S. Food and Drug Administration . . . → Read More: Biogen Idec Inc. (NASDAQ:BIIB) – Sobi’s partner Biogen Idec receives notification from FDA of PDUFA date extension for ALPROLIX(TM) Similar posts: Company Update – Bristol-Myers Squibb Company (NYSE:BMY) – Xigduo™ (dapagliflozin and metformin hydrochloride) receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes Stock Update: Biogen Idec Inc. (NASDAQ:BIIB) – December 27th Options Now Available For Biogen Idec (BIIB) Wal-Mart extends equity conversion date in India’s Cedar – Wal-Mart (WMT)